Fuso Pharmaceutical Industries,Ltd.JP:4538Balance sheet

Market cap
¥22.4B
P/E ratio
8.8x
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Cash and cash equivalents -5,8985,0064,9515,4575,7267,2687,0747,3478,0145,1206,264
Inventories-7,8077,7188,5938,5599,0638,2188,9188,90710,18411,81312,642
Total current assets-37,43135,41836,99537,86638,38838,01139,53339,78743,21944,94748,342
Property, plant and equipment, net-24,45227,23325,18424,98826,53125,44924,63823,79223,76324,42723,111
Marketable securities, non-current -4,0813,6043,6503,8483,9422,9023,2473,0923,0183,9244,375
Total non-current assets-31,19533,63831,79232,32233,29831,14230,34329,54629,24630,85433,386
Total assets -68,62769,05668,78870,18871,68769,15369,87669,33472,46675,80281,729
Short-term debt-3,2502,9502,8502,9902,4102,3502,3502,3502,3502,35018,000
Long-term debt, current -2,8883,2053,0983,5804,1314,1553,8473,5853,3133,351827
Total current liabilities-26,43024,78724,68325,53226,42825,70126,76326,37528,47429,65044,131
Long-term debt, non-current -4,9408,1088,2508,9129,3898,2456,6395,7585,7477,0212,462
Total non-current liabilities-8,65811,65311,55912,07612,41611,1509,4298,4268,3439,4894,554
Total liabilities -35,08836,44036,24237,60838,84436,85136,19334,80236,81739,14048,685
Common stock and paid-in capital -25,76825,76825,76825,76825,76825,76825,76825,76725,76725,70925,709
Retained earnings-12,31311,60012,05712,40912,60412,71913,81514,73115,81116,54112,612
Stockholders' equity34,89233,53832,61632,54532,57932,84232,30233,68334,53235,64936,66133,043